Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated PatientsRitchell van Dams, Amar U. Kishan, Vedang Murthy et al.|International Journal of Radiation Oncology*Biology*Physics|2021Cited by 63
Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic ReviewRobert Foerster, Vedang Murthy, Daniel R. Zwahlen et al.|Cancers|2021Cited by 42
Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate CancerTejshri Telkhade, Rahul Krishnatry, Vedang Murthy et al.|Clinical Oncology|2020Cited by 15
Impact of Adjuvant Treatment in pN3 Penile CancerPallavi Khurud, Vedang Murthy, Rahul Krishnatry et al.|Clinical Oncology|2021Cited by 14
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 323 Prospectively Treated PatientsRitchell van Dams, Amar U. Kishan, Ning Jiang et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 6